Biocept Competitors

BIOCQ Stock   0.0001  0.00  0.00%   
Analyzing Biocept competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Biocept to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Biocept Correlation with its peers.
To learn how to invest in Biocept Stock, please use our How to Invest in Biocept guide.

Biocept vs Nabriva Therapeutics Correlation

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biocept's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00009450.01
Details
Intrinsic
Valuation
LowRealHigh
0.000.000350.01
Details

Biocept Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Biocept and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Biocept and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Biocept does not affect the price movement of the other competitor.

High positive correlations

BSPMHTGMQ
NMSCAHTGMQ
OMDDHTGMQ
NMSCABSPM
OMDDBSPM
OMDDNMSCA
  

High negative correlations

NBRVFOMDD
NBRVFMDVLQ
OMDDMDVLQ
NBRVFCRFTF
OMDDCRFTF
MDVLQCRFTF

Risk-Adjusted Indicators

There is a big difference between Biocept Stock performing well and Biocept Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biocept's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
HTGMQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
BSPM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CWWBF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
PEMTF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
NMSCA  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
VRCI  32.25  16.26  0.00  11.70  0.00 
 0.00 
 0.00 
CRFTF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
MDVLQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
OMDD  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
NBRVF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Biocept Competitive Analysis

The better you understand Biocept competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Biocept's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Biocept's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BIOCQ HTGMQ BSPM NMSCA OMDD
 0.00 
 0.0001 
Biocept
 0.00 
 0.0001 
HTG
 0.00 
 0.0001 
Biostar
 0.00 
 0.0001 
Nutrition
 0.00 
 0.0001 
Ormand
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Short Ratio
Debt To Equity
Target Price
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Rate Of Daily Change
Day Median Price
Day Typical Price
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Standard Deviation
Information Ratio
Kurtosis
Treynor Ratio
Variance

Biocept Competition Performance Charts

Five steps to successful analysis of Biocept Competition

Biocept's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Biocept in relation to its competition. Biocept's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Biocept in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Biocept's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Biocept, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Biocept position

In addition to having Biocept in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run SRI Sustainable Growth Thematic Idea Now

SRI Sustainable Growth
SRI Sustainable Growth Theme
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Biocept Stock Analysis

When running Biocept's price analysis, check to measure Biocept's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocept is operating at the current time. Most of Biocept's value examination focuses on studying past and present price action to predict the probability of Biocept's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocept's price. Additionally, you may evaluate how the addition of Biocept to your portfolios can decrease your overall portfolio volatility.